Lipid mediators and the regulation of macrophage function and colitis

Simple item page
dc.contributor.advisorMcKay, Derek M.
dc.contributor.authorPrescott, David Charles
dc.date.accessioned2017-12-18T22:35:41Z
dc.date.available2017-12-18T22:35:41Z
dc.date.issued2012
dc.descriptionBibliography: p. 184-233en
dc.descriptionA few pages are in colour.en
dc.descriptionIncludes copy of animal protocol approval and copyright permission. Original copies with original Partial Copyright Licence.en
dc.description.abstractThe maintenance of balanced immune responses is vital to the health of an individual. This is of particular importance in the intestine, as it represents a vast immunological challenge due to the enormous antigenic potential of the commensal microbiota. The body has therefore developed a number of homeostatic strategies to ensure that inflammatory reactions are freely able to clear foreign material such as bacteria in a manner that is self-limiting. The dysregulation of these processes, however, can lead to the development of chronic diseases such as inflammatory bowel disease (IBO). A cell type that plays a vital role in maintaining this homeostasis is the macrophage. In this thesis, I have demonstrated how the phagocytosis of bacteria is enhanced in these cells by lipoxins, a family of lipid mediators that are involved in inducing the resolution of inflammation. This phenomenon was associated with a concomitant decrease in pro-inflammatory mediator production, suggesting that lipoxins are able to induce a macrophage phenotype that is geared towards eliminating any residual infections at the end stages of inflammation, and return tissues to sterile homeostasis. The functions of lipoxin were also found to be dependent on the signalling molecule phosphoinositide 3-kinase pl l0y (PI3Ky). This enzyme has previously been shown to be involved in the recruitment of leukocytes to inflamed tissues, and thus its inhibition or genetic knock-out has been shown to effectively treat a number of mouse models of inflammatory disease. We show here that mice deficient in PB Ky are initially protected from acute experimental colitis induced by the haptenizing agent trinitrobenzene sulfonic acid (TNBS), but fail to heal properly due to an inability to clear bacteria that have infected the colonic tissue. Taken together, these studies highlight the importance of bacterial clearance from inflamed tissues, and suggest that the development of novel anti-inflammatory therapies that promote, rather than hinder the antimicrobial functions of phagocytes such as macrophages could be of use in the treatment of IBD.
dc.format.extentxix, 233 leaves : ill. ; 30 cm.en
dc.identifier.citationPrescott, D. C. (2012). Lipid mediators and the regulation of macrophage function and colitis (Doctoral thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/4968en_US
dc.identifier.doihttp://dx.doi.org/10.11575/PRISM/4968
dc.identifier.urihttp://hdl.handle.net/1880/105969
dc.language.isoeng
dc.publisher.institutionUniversity of Calgaryen
dc.publisher.placeCalgaryen
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.titleLipid mediators and the regulation of macrophage function and colitis
dc.typedoctoral thesis
thesis.degree.disciplineGastrointestinal Sciences
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameDoctor of Philosophy (PhD)
ucalgary.item.requestcopytrue
ucalgary.thesis.accessionTheses Collection 58.002:Box 2116 627942986
ucalgary.thesis.notesUARCen
ucalgary.thesis.uarcreleaseyen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
thesis_Prescott_2012.pdf
Size:
102.4 MB
Format:
Adobe Portable Document Format
Description:
Thesis
Download
Collections
Legacy Theses